P.G. Pagella

476 total citations
24 papers, 385 citations indexed

About

P.G. Pagella is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, P.G. Pagella has authored 24 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Pharmacology and 9 papers in Organic Chemistry. Recurrent topics in P.G. Pagella's work include Cholinesterase and Neurodegenerative Diseases (8 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Chemical synthesis and alkaloids (4 papers). P.G. Pagella is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (8 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Chemical synthesis and alkaloids (4 papers). P.G. Pagella collaborates with scholars based in Italy, United Kingdom and Argentina. P.G. Pagella's co-authors include Susan D. Iversen, M. Brufani, Gerard R. Dawson, Graham Bentley, Oriana Tabarrini, Arnaldo Fravolini, Violetta Cecchetti, Wayne Rycroft, M. Pomponi and A. Oliverio and has published in prestigious journals such as Journal of Medicinal Chemistry, Life Sciences and Drugs.

In The Last Decade

P.G. Pagella

24 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.G. Pagella Italy 11 192 151 108 45 44 24 385
Katelijne Anciaux Belgium 6 97 0.5× 182 1.2× 39 0.4× 18 0.4× 66 1.5× 8 459
Valeria Capurro Italy 15 125 0.7× 235 1.6× 57 0.5× 25 0.6× 55 1.3× 29 593
Alain Anselmet France 9 238 1.2× 192 1.3× 29 0.3× 37 0.8× 34 0.8× 15 402
Haresh S. Ved United States 12 162 0.8× 217 1.4× 42 0.4× 56 1.2× 112 2.5× 20 479
Friedemann Gaube Germany 9 118 0.6× 240 1.6× 154 1.4× 19 0.4× 55 1.3× 11 374
Samantha Michaelson Australia 6 203 1.1× 174 1.2× 29 0.3× 22 0.5× 37 0.8× 8 348
Nibha Mishra India 15 81 0.4× 201 1.3× 140 1.3× 50 1.1× 41 0.9× 33 575
Soyong Jang South Korea 12 58 0.3× 185 1.2× 70 0.6× 19 0.4× 51 1.2× 26 390
Nathaniel Wallace United States 11 169 0.9× 119 0.8× 66 0.6× 35 0.8× 66 1.5× 15 483
J. Hillis Miller United States 11 157 0.8× 246 1.6× 132 1.2× 12 0.3× 164 3.7× 13 463

Countries citing papers authored by P.G. Pagella

Since Specialization
Citations

This map shows the geographic impact of P.G. Pagella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.G. Pagella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.G. Pagella more than expected).

Fields of papers citing papers by P.G. Pagella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.G. Pagella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.G. Pagella. The network helps show where P.G. Pagella may publish in the future.

Co-authorship network of co-authors of P.G. Pagella

This figure shows the co-authorship network connecting the top 25 collaborators of P.G. Pagella. A scholar is included among the top collaborators of P.G. Pagella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.G. Pagella. P.G. Pagella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Xuedong, Gabriel Cuadra, M. Brufani, et al.. (1996). Effects of MF‐268, a new cholinesterase inhibitor, on acetylcholine and biogenic amines in rat cortex. Journal of Neuroscience Research. 43(1). 120–126. 9 indexed citations
2.
Wise, Robert A., P.G. Pagella, Violetta Cecchetti, Arnaldo Fravolini, & Oriana Tabarrini. (1995). In Vitro Activity of MF 5137, a New Potent 6-Aminoquinolone. Drugs. 49(Supplement 2). 272–273. 10 indexed citations
3.
Cecchetti, Violetta, Sérgio Clementi, Gabriele Cruciani, et al.. (1995). 6-Aminoquinolones: A New Class of Quinolone Antibacterials?. Journal of Medicinal Chemistry. 38(6). 973–982. 39 indexed citations
4.
Alisi, Maria Alessandra, et al.. (1995). Synthesis and structure-activity relationships of new acetylcholinesterase inhibitors: Morpholinoalkylcarbamoyloxyeseroline derivatives. Bioorganic & Medicinal Chemistry Letters. 5(18). 2077–2080. 14 indexed citations
6.
Zecca, Luigi, et al.. (1993). Determination of heptylphysostigmine in plasma by high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 615(1). 169–173. 5 indexed citations
7.
Rupniak, N.M.J., et al.. (1992). Reversal of cognitive impairment by heptyl physostigmine, a long-lasting cholinesterase inhibitor, in primates. Journal of the Neurological Sciences. 107(2). 246–249. 29 indexed citations
8.
Brufani, Mario, et al.. (1992). Synthesis of some carbamates of myo-inositol. Carbohydrate Research. 228(2). 371–376. 2 indexed citations
9.
Cecchetti, Violetta, Arnaldo Fravolini, Fausto Schiaffella, et al.. (1992). 1,4‐Benzothiazine‐2‐carboxylic acid 1‐oxides as analogues of antibacterial quinolones. Journal of Heterocyclic Chemistry. 29(2). 375–382. 17 indexed citations
10.
Alisi, Maria Alessandra, Mario Brufani, Stefano Maiorana, et al.. (1992). Synthesis of some thiophosphate analogues (C-S-P) of phosphatidylinositol. Tetrahedron Letters. 33(27). 3891–3894. 9 indexed citations
11.
Brufani, M., et al.. (1992). Synthesis of phenothiazine derivatives as potential inhibitors of phospholipase C.. PubMed. 47(5). 585–97. 1 indexed citations
12.
Dawson, Gerard R., et al.. (1991). The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents. Pharmacology Biochemistry and Behavior. 39(4). 865–871. 75 indexed citations
13.
Quaglia, M.G., A. Farina, Paolo Melchiorre, E. Bossù, & P.G. Pagella. (1990). The analytical profile of rufloxacin, a new fluoroquinolone, by reversed-phase high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 8(8-12). 1075–1078. 2 indexed citations
14.
Marta, Maurizio, Claudio Castellano, A. Oliverio, et al.. (1988). New analogs of physostigmine: Alternative drugs for Alzheimer's disease?. Life Sciences. 43(23). 1921–1928. 33 indexed citations
15.
Abbadini, Marzia, et al.. (1987). Antithrombotic Properties of Dermatan Sulphate in a Rat Venous Thrombosis Model. Pathophysiology of Haemostasis and Thrombosis. 17(6). 329–335. 39 indexed citations
16.
Abbadini, Marzia, et al.. (1987). DERMATAN SULPHATE PREVENTS VENOUS THROMBOSIS IN RATS WITHOUT INCREASING BLEEDING. Thrombosis and Haemostasis. 1 indexed citations
17.
Cecchetti, Violetta, Arnaldo Fravolini, Renata Fringuelli, et al.. (1987). Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.. PubMed. 42(1). 61–75. 1 indexed citations
18.
Fantozzi, Roberto, et al.. (1985). Drug modulation of superoxide anion production from human neutrophils.. PubMed. 7(2). 149–52. 8 indexed citations
19.
Pagella, P.G., et al.. (1984). Pharmacological and toxicological studies on an iron succinyl-protein complex (ITF282) for oral treatment of iron deficiency anemia.. PubMed. 34(9). 952–8. 12 indexed citations
20.
Zonta, F, et al.. (1981). Dualism in the α-adrenoceptor blocking action of dihydroergocristine. Pharmacological Research Communications. 13(3). 231–240. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026